Health

Cardiex Awarded $525,000 Grand Prize in NIH RADx Tech for Maternal Health Challenge

SYDNEY, Oct. 16, 2024 /PRNewswire/ -- Cardiex, a global health technology company specializing in cardiovascular diagnostics and devices, today announced it has been awarded the$525,000 grand prize in the US National Institutes of Health (NIH) RADx Tech for Maternal Health Challenge. The award re...

2024-10-16 06:00 1971

AtomVie Global Radiopharma and Radiopharm Theranostics Partner to Develop and Manufacture 177Lu-BetaBart Radioantibody for Treatment of Multiple Solid Tumors

HAMILTON, ON, Oct. 16, 2024 /PRNewswire/ -- AtomVie Global Radiopharma (AtomVie), a leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), has entered into an agreement with Radiopharm Ventures (RV), a Joint Venture between Radiopharm Theranostics (RAD) and MD And...

2024-10-16 05:00 925

PharmAust affirms corporate strategy with name change to Neurizon Therapeutics

MELBOURNE, Australia, Oct. 15, 2024 /PRNewswire/ -- Neurizon Therapeutics Limited (ASX: NUZ) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to advancing treatments for neurodegenerative diseases, is pleased to announce it has officially changed its name from PharmAust L...

2024-10-16 04:14 1243

MDisrupt Secures American Heart Association Ventures Investment, Enters Strategic Collaboration for Association Members

* American Heart Association Ventures invests in MDisrupt * Lisa Suennen, Managing Partner of American Heart Association Ventures and longtime healthcare veteran, joins the MDisrupt board * MDisrupt's marketplace will be made available to thousands of the American Heart Association's profe...

2024-10-16 03:00 1356

RLDatix Appoints Dan Michelson as Chief Executive Officer

Michelson succeeds Jeff Surges who transitions into Board Advisor Role CHICAGO, Oct. 16, 2024 /PRNewswire/ -- RLDatix, a leading global provider of connected healthcare operations software and services, announced today the appointment ofDan Michelson as its new Chief Executive Officer and a membe...

2024-10-15 23:28 1125

Chiglitazar for the Treatment of MASH Phase II Clinical Study Selected for Oral Presentation at the 2024 American Liver Disease Annual Meeting

SHENZHEN, China, Oct. 15, 2024 /PRNewswire/ -- On October 15, 2024, the list of selected candidates for the oral report of the American Association for the Study of the Liver (AASLD 2024) annual meeting was officially announced online. The abstract of the Phase II clinical study (CGZ203 trial) on...

2024-10-15 22:08 1345

Accure Acne Announces New FDA Clearance for the Long-Term Treatment of Acne

The Groundbreaking Accure Laser System is now indicated for the long-term treatment of mild to severe inflammatory acne vulgaris BOULDER, Colo., Oct. 15, 2024 /PRNewswire/ -- Accure Acne, Inc.™ ( www.accureacne.com), a pioneer in the development of innovative solutions for the treatment of acne, ...

2024-10-15 21:50 1036

Operation Smile Featured in "Beyond the Code," a New Branded Series that Explores How AI Is Driving Transformative Change

VIRGINIA BEACH, Va., Oct. 15, 2024 /PRNewswire/ -- Global nonprofit Operation Smile today announced its involvement in Beyond the Code, a new branded series presented by Partnership onAI (PAI) and produced by BBC StoryWorks Commercial Productions. The first of its kind, this online series – which...

2024-10-15 21:00 984

Bloomage Debuts New Products at CPHI Milan to Reinforce Its Commitment to Innovation

MILAN, Oct. 15, 2024 /PRNewswire/ -- Bloomage, a global leader in hyaluronic acid and other bioactive substance innovations, unveiled its Hyatrue® Sterile Sodium Hyaluronate (HA) and showcased its BloomseaN™ Polydeoxyribonucleotide (PDRN) and Polynucleotide (PN) at CPHI Milan. Known to be at "the...

2024-10-15 21:00 749

Neurophet-AriBio to develop 'Next-Gen Platform for Alzheimer's diagnosis'

- Neurophet's brain MRI analysis technology incorporates fluid biomarker data from AriBio's global Phase 3 clinical trial for Alzheimer's disease - Collaborates leveraging Neurophet's medical image analysis technology and AriBio's clinical trial data analysis expertise SEOUL, South Korea, Oct. 1...

2024-10-15 21:00 1207

Prenetics Announces Tencent's US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection

HONG KONG, Oct. 15, 2024 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, today announced thatTencent has made a strategicUS$30 million investment in Insighta, a Hong Kong-based early cancer detection company. This investment values Insighta atUS$200 mill...

2024-10-15 20:50 3532

Gan & Lee Pharmaceuticals' Three Innovative Drugs: GZR18 Injection, GZR4 Injection, and GZR101 Injection Achieve Primary Endpoints in Phase 2 Clinical Studies

* After 24 weeks of treatment in patients with Type 2 diabetes, the bi-weekly GLP-1 receptor agonist GZR18 injection showed superior efficacy in lowering HbA1c and body weight compared to semaglutide (Ozempic®). * After 16 weeks of treatment in patients with Type 2 diabetes, the once-weekly i...

2024-10-15 19:36 1177

Endogenex™ Announces First Patient Enrolled in the ReCET Clinical Study

Achieving a Significant Clinical Milestone in Assessing the ReCET™ System as a Groundbreaking Treatment for Type 2 Diabetes MINNEAPOLIS, Oct. 15, 2024 /PRNewswire/ -- Endogenex, Inc., a clinical-stage medical device company focused on improving outcomes for patients with type 2 diabetes (T2D), t...

2024-10-15 19:32 931

Empowering Experience through Digital, Humanizing Technology for All: vivo Unveils Vision in the Future of Mobile Imaging at the Global Imaging Press Conference

BEIJING, Oct. 15, 2024 /PRNewswire/ -- vivo, a global leader in mobile technology, successfully convened the 2024 vivo Global Imaging Press Conference inBeijing today, bringing together over 100 global media representatives. Following the unveiling of the latest vivo X200 series, the conference e...

2024-10-15 17:51 1255

Fapon showcases its total IVD solutions at Hospital Expo to empower local Indonesian IVD industry

DONGGUAN, China, Oct. 15, 2024 /PRNewswire/ -- Fapon, a global leading life sciences company, is excited to participate in the Hospital Expo inJakarta, Indonesia, from October 16 – 19. Fapon will showcase its total IVD solutions, including IVD raw materials, reagent services and open-system instr...

2024-10-15 16:28 1314

Clarivate Repeats Success in Nobel Prize Predictions with Eight New Winners Identified by Citation Laureates Program

83 Citation Laureates named by the Institute for Scientific Information have received a Nobel Prize since 2002 LONDON, Oct. 15, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the success of its annualCitation Laureates™ p...

2024-10-15 15:00 1092

DBN Group Invites Global Agricultural Biotech Companies to Co-create a Leading Innovation Ecosystem at DBN Phoenix International Innovation Park

BEIJING, Oct. 15, 2024 /PRNewswire/ -- DBN Group , a leading high-tech agricultural enterprise, has opened its Phoenix International Innovation Park for global applications from high-quality agricultural biotech companies. This initiative seeks to establish an ope...

2024-10-15 13:45 1576

Aidoc and Integral Diagnostics (IDX) Expand AI Partnership in Australia and New Zealand

Aidoc's AI technology enhances radiology services at IDX, significantly improving patient care and service and well-placed to support the upcoming National Lung Cancer Screening Program. MELBOURNE, Australia, Oct. 15, 2024 /PRNewswire/ -- Aidoc, a global pioneer in clinical AI solutions, today a...

2024-10-15 11:28 1168

PharmAbcine Announces Safety Approval for 4mg Single-dose Cohort in Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration

* Safety Review Committee (SRC) approves single ascending dose 4mg cohort in Phase 1 trial of PMC-403, preparing for multiple ascending dose 4 mg cohort. * PMC-403 is being explored in broader therapeutic areas, including rare vascular disease systemic capillary leak syndrome (SCLS) and kidney...

2024-10-15 09:51 1211

CooperVision to Host 4th Asia-Pacific Myopia Management Symposium in Seoul, South Korea

Held in partnership with the Korean Association of Paediatric Ophthalmology and Strabismus (KAPOS), the event will focus on advancing paediatric myopia management and shaping the future of eye health across the region. SINGAPORE, Oct. 15, 2024 /PRNewswire/ -- CooperVision

2024-10-15 09:00 3439
1 ... 19202122232425 ... 861